For a full list of publications visit Google Scholar

Publication highlights

Assessment of anti-CD20 antibody pre-treatment for augmentation of CAR-T cell therapy in SIV-infected rhesus macaques

Pampusch, M. S., Sevcik, E. N., Quinn, Z. E., Davey, B. C., Berg, J. M., Gorrell-Brown, I., Abdelaal, H. M., Rakasz, E. G., Rendahl, A. & Skinner, P. J., Feb 7 2023, In: Frontiers in immunology. 14, 1101446.

Development of an anti-CAR antibody response in SIV-infected rhesus macaques treated with CD4-MBL CAR/CXCR5 T cells

Davey, B. C., Pampusch, M. S., Cartwright, E. K., Abdelaal, H. M., Rakasz, E. G., Rendahl, A., Berger, E. A. & Skinner, P. J., Dec 13 2022, In: Frontiers in immunology. 13, 1032537.

HIV-Specific CAR T Cells with CD28 or 4-1BB Signaling Domains Are Phenotypically and Functionally Distinct and Effective at Suppressing HIV and Simian Immunodeficiency Virus

Cartwright, E. K., Pampusch, M. S., Rendahl, A. K., Berger, E. A., Coleman-Fuller, N. & Skinner, P. J., Oct 1 2022, In: ImmunoHorizons. 6, 10, p. 693-704 12 p.

CAR/CXCR5-Tcell immunotherapy is safe and potentially efficacious in promoting sustained remission of SIV infection

Pampusch, M. S., Abdelaal, H. M., Cartwright, E. K., Molden, J. S., Davey B. C., Sauve, J. D., Sevcik, E. N., Rendahl, A. K., Rakasz, E. G., Connick, E., Berger, E. A., & Skinner, P. J., Feb 7 2022, In: PLoS Pathogens. 18, 2, e100983

Production and Characterization of SIV-Specific CAR/CXCR5 T Cells

Pampusch, M. S., Hajduczki, A., Mwakalundwa, G., Connick, E., Berger, E. A. & Skinner, P. J., 2022, Methods in Molecular Biology. Humana Press Inc., Vol. 2421. p. 171-185 15 p. (Methods in molecular biology (Clifton, N.J.)).

Rapid Transduction and Expansion of Transduced T Cells with Maintenance of Central Memory Populations

Pampusch, M. S., Haran, K. P., Hart, G. T., Rakasz, E. G., Rendahl, A. K., Berger, E. A., Connick, E. & Skinner, P. J., Mar 13 2020, In: Molecular Therapy - Methods and Clinical Development. 16, p. 1-10 10 p.